breast cancer
Conditions
Interventions
Index test:serum SEMA4C test
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients older than 18 years; 2. Patients willing to participate as evidenced by signing the written informed consent form; 3. Patient highly suspicious for breast cancers, which was confirmed by two breast cancer specialists according to abnormal clinical findings (including but not limited to mammographic lesions, ultrasound lesions and symptoms); 4. Patients enrolled before initiation of any kind of treatment (including but not limited to chemotherapy, radiotherapy, hormone therapy and surgery); 5. Patients with scheduled surgical biopsies or mastectomies for breast lesions within 15 days after enrollment.
Exclusion criteria
Exclusion criteria: 1. Patients with known active inflammatory or autoimmune diseases; 2. Patients with known renal or liver diseases; 3. Patients with a diagnosis of other severe acute or chronic medical conditions that may interfere with the interpretation of the study results; 4. Patients with any known cancer in other internal organs or systems or a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN [cervical intra-epithelial neoplasia]) within 5 years; 5. Patients with mental abnormal; 6. Patients did not cooperate or participate in other clinical trials 7. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;AUC; | — |
Countries
China
Contacts
Public ContactGao Qinglei
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed